Péter Kardos

4.7k total citations
134 papers, 2.9k citations indexed

About

Péter Kardos is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Emergency Medical Services. According to data from OpenAlex, Péter Kardos has authored 134 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Pulmonary and Respiratory Medicine, 79 papers in Physiology and 31 papers in Emergency Medical Services. Recurrent topics in Péter Kardos's work include Asthma and respiratory diseases (74 papers), Respiratory and Cough-Related Research (68 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (57 papers). Péter Kardos is often cited by papers focused on Asthma and respiratory diseases (74 papers), Respiratory and Cough-Related Research (68 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (57 papers). Péter Kardos collaborates with scholars based in Germany, United Kingdom and United States. Péter Kardos's co-authors include Claus Vogelmeier, H. Worth, Thomas Glaab, Marion Wencker, Roland Buhl, Paul Jones, Thys van der Molen, Norbert Banik, T. Pérez and Roberto Walter Dal Negro and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Péter Kardos

122 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Péter Kardos Germany 27 2.2k 1.5k 270 261 221 134 2.9k
Roberto W. Dal Negro Italy 22 1.3k 0.6× 1.1k 0.7× 180 0.7× 114 0.4× 100 0.5× 116 1.9k
Melvin R. Pratter United States 26 2.4k 1.1× 1.6k 1.0× 460 1.7× 228 0.9× 292 1.3× 78 2.9k
Michael Schatz United States 29 2.0k 0.9× 2.7k 1.8× 222 0.8× 242 0.9× 445 2.0× 77 3.9k
Ki‐Suck Jung South Korea 25 1.2k 0.6× 687 0.5× 153 0.6× 447 1.7× 176 0.8× 165 2.5k
Andrew McIvor Canada 29 1.9k 0.9× 1.8k 1.2× 132 0.5× 385 1.5× 147 0.7× 106 3.0k
J. Mark FitzGerald Canada 27 1.7k 0.8× 1.3k 0.8× 101 0.4× 507 1.9× 415 1.9× 58 2.8k
Joan Serra-Batllés Spain 12 1.2k 0.5× 688 0.5× 65 0.2× 580 2.2× 135 0.6× 21 2.0k
Paul Dorinsky United States 34 3.3k 1.5× 2.9k 1.9× 128 0.5× 374 1.4× 261 1.2× 162 4.2k
Matthew Masoli United Kingdom 16 2.1k 1.0× 2.9k 1.9× 281 1.0× 141 0.5× 230 1.0× 41 3.5k
Shaun Holt New Zealand 11 1.7k 0.8× 2.4k 1.6× 252 0.9× 139 0.5× 172 0.8× 26 3.0k

Countries citing papers authored by Péter Kardos

Since Specialization
Citations

This map shows the geographic impact of Péter Kardos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Kardos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Kardos more than expected).

Fields of papers citing papers by Péter Kardos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Kardos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Kardos. The network helps show where Péter Kardos may publish in the future.

Co-authorship network of co-authors of Péter Kardos

This figure shows the co-authorship network connecting the top 25 collaborators of Péter Kardos. A scholar is included among the top collaborators of Péter Kardos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Kardos. Péter Kardos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vogelmeier, Claus, Kai Michael Beeh, Péter Kardos, et al.. (2024). Baseline patient demographics for TETRIS: a prospective, noninterventional study to characterize the use of triple therapy for COPD in Germany. Therapeutic Advances in Respiratory Disease. 18. 2693866949–2693866949.
2.
Smith, Andrew C., Péter Kardos, Oliver Pfaar, et al.. (2023). The treatment of mild upper respiratory tract infections – a position paper with recommendations for best practice. Drugs in Context. 12. 1–15. 8 indexed citations
3.
Vogelmeier, Claus, et al.. (2022). Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD ‘real world’ study. Respiratory Research. 23(1). 109–109. 7 indexed citations
4.
Fletcher, Monica, Ioanna Tsiligianni, Janwillem Kocks, et al.. (2020). Improving primary care management of asthma: do we know what really works?. npj Primary Care Respiratory Medicine. 30(1). 29–29. 27 indexed citations
5.
6.
Gillissen, Adrian, Christian Geßner, Felix Herth, et al.. (2018). Patient Satisfaction and Clinical Outcomes with Budesonide plus Formoterol Spiromax for Asthma and Chronic Obstructive Pulmonary Disease: A Real-World, Observational Trial. Respiration. 97(4). 292–301. 6 indexed citations
7.
D’Urzo, Anthony, et al.. (2018). Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD. International Journal of COPD. Volume 13. 1089–1104. 9 indexed citations
8.
Vogelmeier, Claus, H. Worth, Roland Buhl, et al.. (2017). “Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD. International Journal of COPD. Volume 12. 487–494. 44 indexed citations
9.
10.
Worth, H., Roland Buhl, Carl-Peter Criée, et al.. (2017). GOLD 2017 treatment pathways in ‘real life’: An analysis of the DACCORD observational study. Respiratory Medicine. 131. 77–84. 23 indexed citations
11.
Young, David, Roland Buhl, Carl-Peter Criée, et al.. (2016). A year in the life of German patients with COPD: the DACCORD observational study. International Journal of COPD. Volume 11. 1639–1646. 23 indexed citations
12.
Vogelmeier, Claus, Roland Buhl, Carl-Peter Criée, Péter Kardos, & H. Worth. (2014). Frequency of COPD exacerbations in the real-life out-patient DACCORD cohort. European Respiratory Journal. 44(Suppl 58). P930–P930. 2 indexed citations
13.
Kardos, Péter, et al.. (2013). Effect of roflumilast on quality of life in frequent and infrequent exacerbators. European Respiratory Journal. 42(Suppl 57). P4150–P4150. 1 indexed citations
14.
15.
Jones, Paul, Guy Brusselle, Roberto Walter Dal Negro, et al.. (2011). Properties of the COPD assessment test in a cross-sectional European study. European Respiratory Journal. 38(1). 29–35. 268 indexed citations
16.
Brüggenjürgen, Bernd, et al.. (2010). Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatment. Allergy. 65(9). 1108–1115. 12 indexed citations
17.
Kardos, Péter, Marion Wencker, Thomas Glaab, & Claus Vogelmeier. (2007). Avoiding Mistakes in Calculating the Number Needed to Treat in Severe COPD. American Journal of Respiratory and Critical Care Medicine. 175(12). 1347–1348. 1 indexed citations
18.
Kardos, Péter, Marion Wencker, Thomas Glaab, & Claus Vogelmeier. (2006). Impact of Salmeterol/Fluticasone Propionate versus Salmeterol on Exacerbations in Severe Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 175(2). 144–149. 245 indexed citations
19.
Schultze‐Werninghaus, G., Péter Kardos, Dietrich Berdel, et al.. (2006). Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma 2005. Medizinische Klinik. 101(1). 60–64. 8 indexed citations
20.
Kirchner, Johannes, Volkmar Jacobi, Péter Kardos, & J Kollath. (1998). CT findings in extensive tracheobronchial amyloidosis. European Radiology. 8(3). 352–354. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto W. Dal Negro Breakdown of academic impact, for papers by Melvin R. Pratter Breakdown of academic impact, for papers by Michael Schatz Breakdown of academic impact, for papers by Ki‐Suck Jung Breakdown of academic impact, for papers by Andrew McIvor Breakdown of academic impact, for papers by J. Mark FitzGerald Breakdown of academic impact, for papers by Joan Serra-Batllés Breakdown of academic impact, for papers by Paul Dorinsky Breakdown of academic impact, for papers by Matthew Masoli Breakdown of academic impact, for papers by Shaun Holt
Rankless by CCL
2026